BrightSpring Health Stock Near 52-Week High with $81 Price Target
BTSG•BrightSpring Health Services stock trades near its 52-week high of $65 after climbing from a $19 low, giving it a $12.6 billion market cap. A new $81 price target implies 25.7% upside as cash flow grows, 2026 earnings estimates rise 10.6%, and tuck-in deals drive 20% revenue gains.
1. Stock Performance and Valuation
BrightSpring Health Services stock is trading at $64.43, just below its 52-week high of $65.00 and well above its 52-week low of $19.01, resulting in a market capitalization of approximately $12.64 billion.
2. Analyst Price Target Revision
An analyst has raised the price target to $81.00, reflecting a potential upside of 25.7% from the current share price and signaling growing confidence in the company’s valuation.
3. Financial Metrics Improvement
The company has reported strong cash flow growth alongside a 10.6% increase in its 2026 earnings estimates, underscoring improved operating performance and profitability prospects.
4. Growth Strategy and Deals
BrightSpring’s specialty pharmacy segment and tuck-in acquisitions have driven roughly 20% top-line growth and 25%–30% EBITDA growth, supported by securing 16–20 limited distribution drugs annually in oncology and rare disease categories.
